Latest Insider Transactions at Bio Xcel Therapeutics, Inc. (BTAI)
This section provides a real-time view of insider transactions for Bio Xcel Therapeutics, Inc. (BTAI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BioXcel Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BioXcel Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 24
2020
|
Bio Xcel Holdings, Inc. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
160,000
+50.0%
|
$9,600,000
$60.76 P/Share
|
|
Jul 24
2020
|
Bio Xcel Holdings, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
160,000
-1.74%
|
$9,600,000
$60.76 P/Share
|
|
Jul 24
2020
|
Krishnan Nandabalan Director |
BUY
Other acquisition or disposition
|
Direct |
80,000
+50.0%
|
$4,800,000
$60.76 P/Share
|
|
Jul 24
2020
|
Krishnan Nandabalan Director |
SELL
Other acquisition or disposition
|
Indirect |
160,000
-1.74%
|
$9,600,000
$60.76 P/Share
|
|
Jul 24
2020
|
Vimal Mehta CEO and President |
BUY
Other acquisition or disposition
|
Direct |
80,000
+50.0%
|
$4,800,000
$60.76 P/Share
|
|
Jul 24
2020
|
Vimal Mehta CEO and President |
SELL
Other acquisition or disposition
|
Indirect |
160,000
-1.74%
|
$9,600,000
$60.76 P/Share
|
|
Apr 01
2019
|
Krishnan Nandabalan Director |
BUY
Bona fide gift
|
Indirect |
1,000
+50.0%
|
-
|
|
Apr 01
2019
|
Krishnan Nandabalan Director |
SELL
Bona fide gift
|
Direct |
1,000
-100.0%
|
-
|
|
Mar 12
2018
|
Vimal Mehta CEO and President |
BUY
Open market or private purchase
|
Indirect |
2,000
+50.0%
|
$22,000
$11.0 P/Share
|